David Collingridge: Our Lancet Oncology Commission Featured in ASCO2026 Opening Session
David Collingridge/LinkedIn

David Collingridge: Our Lancet Oncology Commission Featured in ASCO2026 Opening Session

David Collingridge, Editor in Chief at The Lancet Oncology, shared a post on LinkedIn:

“Our latest Commission graciously mentioned by ASCO President, Dr Eric Small, in the Opening Session of this year’s Congress. If you’re in Chicago or watching online come along to the session: A Workforce Crisis—A Lancet Oncology Commission; May 31, 2026, 4:30 PM-5:45 PM CDT.”

David Collingridge

Other articles featuring The Lancet Oncology on OncoDaily.